Tolvaptan

Details

Files

Generic Name:

Tolvaptan

Project Status:

Complete

Therapeutic Area:

Hyponatremia, non-hypovolemic

Manufacturer:

Otsuka Canada Pharmaceutical Inc.

Call for patient/clinician input open:

July 3, 2012

Brand Name:

Samsca

Project Line:

Reimbursement Review

Project Number:

SR0283-000

Call for patient/clinician input closed:

July 24, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Hyponatremia, non-hypovolemic

Recommendation Type:

Do not list

Final Recommendation:

February 13, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 3, 2012